ConductScience.org, home
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
API referenceFor AI assistants

Trial · NCT00808067

Adverse events1,414

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,414

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousAnaemiaBlood and lymphatic system disordersDabigatran 110 mg232,914
seriousAnaemiaBlood and lymphatic system disordersDabigatran 150 mg362,937
seriousCoagulopathyBlood and lymphatic system disordersDabigatran 110 mg12,914
seriousCoagulopathyBlood and lymphatic system disordersDabigatran 150 mg22,937
seriousDisseminated intravascular coagulationBlood and lymphatic system disordersDabigatran 110 mg22,914
seriousDisseminated intravascular coagulationBlood and lymphatic system disordersDabigatran 150 mg02,937
seriousHaemolytic anaemiaBlood and lymphatic system disordersDabigatran 110 mg12,914
seriousHaemolytic anaemiaBlood and lymphatic system disordersDabigatran 150 mg12,937
seriousHaemorrhagic anaemiaBlood and lymphatic system disordersDabigatran 110 mg12,914
seriousHaemorrhagic anaemiaBlood and lymphatic system disordersDabigatran 150 mg42,937
seriousHeparin-induced thrombocytopeniaBlood and lymphatic system disordersDabigatran 110 mg02,914
seriousHeparin-induced thrombocytopeniaBlood and lymphatic system disordersDabigatran 150 mg12,937
seriousIron deficiency anaemiaBlood and lymphatic system disordersDabigatran 110 mg42,914
seriousIron deficiency anaemiaBlood and lymphatic system disordersDabigatran 150 mg12,937
seriousLeukopeniaBlood and lymphatic system disordersDabigatran 110 mg02,914
seriousLeukopeniaBlood and lymphatic system disordersDabigatran 150 mg12,937
seriousLymphadenopathyBlood and lymphatic system disordersDabigatran 110 mg12,914
seriousLymphadenopathyBlood and lymphatic system disordersDabigatran 150 mg02,937
seriousMicrocytic anaemiaBlood and lymphatic system disordersDabigatran 110 mg12,914
seriousMicrocytic anaemiaBlood and lymphatic system disordersDabigatran 150 mg02,937

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00808067/events

API referenceFor AI assistants